Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Angewandte Chemie (International Ed. in English)|February 17, 2016
Re-engineering the Immune Response to Metastatic Cancer: Antibody-Recruiting Small Molecules Targeting the Urokinase ReceptorAnthony F Rullo, Kelly J Fitzgerald, Viswanathan Muthusamy, et al.
Oral Oncology|April 7, 2020
Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neckAlec J Kacew, Ethan J Harris, Jochen H Lorch, et al.
Oral Oncology|April 30, 2026
Clearance of circulating HPV DNA during chemoradiation using a next-generation sequencing liquid biopsyMina Bakhtiar, Yana Al-Inaya, Dipon Das, et al.
Cancer|September 14, 2020
Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastasesJack M Qian, Allison M Martin, Kate Martin, et al.
Frontiers in Oncology|April 16, 2019
Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 TherapyMuhammad Mohsin Fareed, Luke R G Pike, Andrew Bang, et al.
Head & Neck|August 21, 2020
Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatinMona Arbab, Yu-Hui Chen, Shana Criscitiello, et al.
Oral Oncology|September 24, 2017
Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapyDanielle N Margalit, Jonathan D Schoenfeld, Bhupendra Rawal, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 20, 2022
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity CancersHina Shah, Yating Wang, Su-Chun Cheng, et al.
JCI Insight|February 23, 2018
Frameshift events predict anti-PD-1/L1 response in head and neck cancerGlenn J Hanna, Patrick Lizotte, Megan Cavanaugh, et al.
Head & Neck|December 20, 2021
Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomesKevin Tyan, Ji Eun Bae, Jochen H Lorch, et al.
Pageof 14